Literature DB >> 12560110

CI-1010 induced opening of the mitochondrial permeability transition pore precedes oxidative stress and apoptosis in SY5Y neuroblastoma cells.

Terry J Miller1, Amanda D Phelka, Ronald B Tjalkens, Lloyd A Dethloff, Martin A Philbert.   

Abstract

The hetero-bifunctional nitroimidazole radiosensitizer CI-1010, R-alpha-[[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazole-1-ethanol monohydrobromide, causes selective irreversible apoptotic loss of retinal photoreceptor cells in vivo. The human neuroblastoma cell line, SH-SY5Y, was used as a neuronotypic model of CI-1010-mediated retinal degeneration. Exposure to CI-1010 for 24 h induced apoptosis in neuroblastoma cells, as determined by histopathological and ultrastructural analysis and by TUNEL technique. CI-1010 causes a dose-dependent decrease in cell viability in SY5Y cells, as measured by the reduction of MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Superoxide dismutase reduced loss of cell viability following CI-1010 treatment suggesting an oxidative stress-mediated mechanism of toxicity. The effects of CI-1010 on mitochondrial membrane potential and intracellular levels of reactive oxygen species were assessed in live SY5Y cells by confocal microscopy using the fluorescent dyes, tetramethylrhodamine methyl ester and 5,6-carboxy-2',7'-dihydrodichlorofluorescein diacetate. CI-1010 caused a rapid depolarization of mitochondria in SY5Y cells followed by an increase in ROS. Both CI-1010-induced mitochondrial depolarization and subsequent increases in ROS were prevented by pretreatment with either the permeability transition pore inhibitor, cyclosporin A (CsA), and by the antioxidant, alpha-tocopherol. However, CsA and alpha-tocopherol were unable to prevent apoptosis in CI-1010-treated cells, suggesting the influence of additional mechanism(s) of CI-1010-induced toxicity. This study evaluates intracellular oxidative stress associated with pore opening prior to apoptosis and provides evidence in support of a mitochondrial mechanism of CI-1010-induced neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560110     DOI: 10.1016/s0006-8993(02)03838-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Effects of tissue transglutaminase on beta -amyloid1-42-induced apoptosis.

Authors:  Joseph J Wakshlag; Marc A Antonyak; Jason E Boehm; Karen Boehm; Richard A Cerione
Journal:  Protein J       Date:  2006-01       Impact factor: 2.371

2.  Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice.

Authors:  Lisiane B Meira; Catherine A Moroski-Erkul; Stephanie L Green; Jennifer A Calvo; Roderick T Bronson; Dharini Shah; Leona D Samson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

3.  N-acetylcysteine protects Chinese Hamster ovary cells from oxidative injury and apoptosis induced by microcystin-LR.

Authors:  Lijian Xue; Jinhui Li; Yang Li; Chu Chu; Guantao Xie; Jin Qin; Mingfeng Yang; Donggang Zhuang; Liuxin Cui; Huizhen Zhang; Xiaoli Fu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Ciclosporin does not attenuate intracranial hypertension in rats with acute hyperammonaemia.

Authors:  Rikke Hebo Larsen; Mette S Kjær; Martin Eefsen; Fin Stolze Larsen; Peter Nissen Bjerring
Journal:  World J Hepatol       Date:  2013-09-27

Review 5.  Evidence for oxidative/nitrosative stress in the pathogenesis of hepatic encephalopathy.

Authors:  Chantal Bemeur; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-03-02       Impact factor: 3.584

Review 6.  New concepts in the mechanism of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao; K S Panickar
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

7.  The Role of Mitochondria in AMD: Current Knowledge and Future Applications.

Authors:  Mohammad Riazi-Esfahani; Baruch D Kuppermann; M Cristina Kenney
Journal:  J Ophthalmic Vis Res       Date:  2017 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.